COVID-19 Lockdown : Sri city units engages in producing quality healthcare products
Andhra Pradesh

COVID-19 Lockdown : Sri city units engages in producing quality healthcare products

Agency News

Sri City, Apr 17: Amid all restrictions due to nation-wide lockdown imposed to contain the spread of COVID-19 and feeling the urgency, some Sri City units, -- Pals Plush India, VRV Asia Pacific, Vital Paper and TIL Healthcare-- are engaged in producing quality healthcare products, ranging from high quality Personal Protection Equipment (PPE) kits to lifesaving drugs to emergency Hospital Bed to medical oxygen cylinders.

A statement here on Friday said, Pals Plush India, a manufacturer of soft toys and accessories, operating at Sri City has begun manufacture of Personal Protection Equipment (PPE) kits for the medical fraternity and other front-liners, who are all relentlessly battling the coronavirus pandemic.

It produces the kits using the seamless metal detection machines with the Acceptable Quality Limit based in-house testing facility, which make the product safe for the end-users. The company has dedicated its entire production capability for manufacturing these high quality PPE kits, including coverall and face shield.

Responding to the Covid-19 crisis, VRV Asia Pacific Private Limited, a Chart Group (USA) company, that designs and manufactures cryogenic equipment at its unit in Sri City, is producing superior quality liquid cylinders and Storage tanks for storing liquid oxygen (LOX).

As there is an alarming spike in the number of positive COVID-19 cases in the country, demand for medical oxygen in hospitals is increasing day-by-day. So as to cope up with this demand, more and more liquid oxygen cylinders are needed. To meet this emergency, VRV, which is one of the two companies in the country that make cryogenic storage cylinders and tanks, swung into action.

TIL Healthcare, the international pharmaceutical arm of the Jhaver Group of companies, produces a host of medicines, including a few life saving drugs, at its pharmaceutical formulation manufacturing facility in Sri City. Now, the government licensed the company to produce HydroxyChloroquine Sulfate (HCQS) tablets.

As soon as raw material is received, TIL Healthcare will start manufacturing of HCQS Tablets, the statement said.(UNI)

pennews
www.pennews.net